Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired nephrogenic diabetes insipidus.

Apurv Khanna1

  • 1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA. Apurv.khanna@ttuhsc.edu

Seminars in Nephrology
|May 23, 2006
PubMed
Summary

Nephrogenic diabetes insipidus (NDI) is a kidney disorder where the nephron is insensitive to antidiuretic hormone. Diagnosis involves a water-deprivation test, and treatment focuses on the underlying cause or specific medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Rare Mechanism of Hyponatremia in HIV Disease.

The American journal of case reports·2015
Same author

Acquired reactive perforating dermatosis: a rare skin manifestation in end stage renal disease.

Nephrology (Carlton, Vic.)·2014
Same author

The management of hyponatremia in HIV disease.

Journal of nephrology·2014
Same author

Hypercalcemia: an unusual manifestation of uterine leiomyoma.

Case reports in medicine·2013
Same author

The management of hyponatremia in HIV disease.

Journal of nephrology·2012
Same author

Vesicoureteral Reflux, a Scarred kidney, and Minimal Proteinuria: An Unusual Cause of Adult Secondary Hypertension.

Case reports in medicine·2011

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Nephrogenic diabetes insipidus (NDI) is characterized by the kidney's inability to concentrate urine due to distal nephron insensitivity to arginine vasopressin.
  • This condition can be congenital or acquired, with acquired NDI often linked to drugs like lithium or metabolic issues such as hypokalemia and hypercalcemia.
  • The molecular basis of acquired NDI involves disruption of the aquaporin-2 shuttle mechanism.

Purpose of the Study:

  • To define Nephrogenic diabetes insipidus (NDI).
  • To outline the diagnostic criteria and underlying molecular mechanisms of NDI.
  • To discuss current and potential therapeutic strategies for NDI.

Main Methods:

  • Diagnosis of NDI is typically established through a water-deprivation test.
  • Assessment involves measuring urinary osmolality before and after vasopressin administration.
  • Identifying and addressing the underlying cause or drug exposure is crucial.

Main Results:

  • Patients with NDI exhibit low urinary osmolality (<300 mosm/kg H2O) even after water deprivation.
  • Little to no increase in urine osmolality is observed following aqueous vasopressin administration.
  • Disturbance in aquaporin-2 function is identified as the core molecular defect in acquired NDI.

Conclusions:

  • NDI is a significant renal disorder stemming from impaired water reabsorption in the kidneys.
  • Effective management requires identifying and rectifying the root cause, drug cessation, or employing specific pharmacological interventions.
  • Therapeutic options include diuretics, NSAIDs, dietary modifications, and desmopressin (DDAVP).

Related Experiment Videos